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Background: One of the major challenges health care systems face in modern time is treating chronic disorders.
In recent years, the increasing occurrence of multiple chronic disorders (MCC) in single individuals has compounded
the complexity of health care. In 2008, it was estimated that worldwide as many as one quarter of the population
between the ages of sixty five to sixty nine suffered from two or more chronic conditions and this prevalence rose
with age. Clinical guidelines provide guidance for management of single disorders, but not for MCC. The aim of the
present study was the study of the prevalence, distribution and impact of MCC in a large Israeli health system.
Methods: We performed a cross-sectional study of MCC in the Maccabi Healthcare System (MHS), Israel’s second
largest healthcare service, providing care for approximately two million people. Data regarding chronic conditions was
collected through electronic medical records and organizational records, as was demographic and socioeconomic data.
Age and sex specific data were compared with previously published data from Scotland.
Results: Two thirds of the population had two or more chronic disorders. This is significantly higher than previously
published rates. A correlation between patient age and number of chronic disorders was found, as was a correlation
between number of chronic disorders and low socioeconomic status, with the exception of children due to a high
prevalence of learning disabilities, asthma, and visual disturbances.
Discussion: MCC is very prevalent in the MHS population, increases with age, and except for children is more
prevalent in lower socioeconomic classes, possibly due to the a combination of the structure of the Israeli universal
insurance and requirements of the ministry of education for exemptions and benefits. A higher than previously
reported prevalence of MCC may be due to the longtime use of use of integrated electronic medical records.
Conclusions: To effectively deal with MCC health care systems must devise strategies, including but not limited to,
information technologies that enable shared teamwork based on clinical guidelines which address the problem of
multiple, as opposed to single chronic disorders in patients.Background
In recent years, ageing of the world population com-
bined with the effects of urbanization and globalization,
an increase in communicable and non-communicable
disorders, patients presenting with multiple complex dis-
eases has occurred [1]. To effectively deal with chronic
disorders, guidelines and quality improvement measures
based on evidence from randomized controlled clinical
trials have been developed. Typically, these guidelines* Correspondence: arbelle_j@mac.org.il
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tions. According to the 2008 World Health Organization
(WHO) report [1], as many as 25% of 65–69 year olds and
50% of 80–84 year olds are affected by two or more
chronic health conditions simultaneously. Recognizing the
problem, and having estimated that in the USA over 25%
of the general population has multiple chronic conditions
(MCC), the National Quality Forum (NQF) under con-
tract with the Department of Health and Human Services
in the USA developed a measurement framework for indi-
viduals with MCC to be used in future NQF recommen-
dations [2]. The epidemiology of MCC has been studiedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Chronic conditions included in multiple chronic
condition analysis
1 Hypertension 21 Atrial fibrillation
2 Depression 22 Peripheral vascular
disease
3 Painful condition 23 Heart failure
4 Asthma 24 Prostate disorders
5 Coronary heart disease 25 Glaucoma
6 Treated dyspepsia 26 Epilepsy
(currently treated)
7 Diabetes mellitus 27 Dementia
8 Thyroid disorders 28 Schizophrenia/
psychosis and
bipolar disorder
9 Rheumatoid arthritis, other
inflammatory polyarthropathies &
systematic connective tissue disorders
29 Psoriasis or eczema
10 Deafness/Hearing Loss 30 Inflammatory
bowel disease
11 Chronic obstructive pulmonary disease 31 Migraine




13 Irritable bowel syndrome 33 Chronic sinusitis
14 Neoplasia/Cancer 34 Learning
disability/ADHD
15 Alcohol problems 35 Anorexia or
bulimia
16 Other psychoactive substance misuse 36 Bronchiectasis
17 Treated constipation 37 Parkinson’s
disease
18 Stroke & transient ischemic attack 38 Multiple sclerosis
19 Chronic kidney disease 39 Chronic viral
hepatitis
20 Diverticular disease of intestine 40 Chronic liver disease
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Denmark [5], England [6], Sweden [7], Germany [8], the
Netherlands [9], and most recently Scotland [10]. A com-
mon observation has been that the incidence of MCC in-
creases as the population’s age increases and appears at
an earlier age in deprived as opposed to wealthy popu-
lations. The implications of MCC are myriad, far reaching
and differ depending on whether the perspective is that
of society, the healthcare system, or the individual [2].
Care for the individual patient with MCC is often frag-
mented, split between providers leading to inefficient, in-
complete and ineffective care. The individual with MCC is
at risk for preventable adverse drug events [11], avoidable
hospital admissions [12] and mortality [13]. Boyd et al.
have estimated that a patient with five co-morbid condi-
tions, treated according to clinical guidelines, would result
in the prescription of 19 doses of 12 different medica-
tions taken at five time points during the day and carry-
ing the risk of ten attendant interactions or adverse events
[14]. Treatments for one disease can be considered either
synergic or contradictory for other conditions. While
trying to improve a patient’s health, one might actually
be harming the patient in another aspect leading to in-
creased hospitalization, increased burden on primary care
physicians [5], increased consults and spiraling healthcare
costs [15].
From a healthcare system perspective MCC is expen-
sive [15] with a major part of the burden falling on the
shoulders’ of primary care providers [6]. We have previ-
ously shown that in Israel hypertension, diabetes mellitus
and female infertility treatments impose an economic bur-
den comparable with that of cancer and cardiovascular
diseases [16]. In the USA among Medicare insurers 80%
of expenses are devoted to patients with four or more
chronic conditions and costs increase exponentially as
patients accrue chronic conditions [15]. MCC is thus
a threat not only to the patient’s health but to health-
care systems’ economic sustainability as well.
Facing the complexity of MCC, and in order to plan
an effective local strategy to deal with the issue of indi-
vidual and organizational risk, the first step is to diag-
nose the extent and complexity of MCC at the local level.
We therefore set out to examine MCC in the Maccabi
Healthcare Service (MHS). Various measures have been
used to define and measure MCC [2,17]. The National
Quality Forum has recently proposed the following defin-
ition: People with two or more concurrent chronic condi-
tions that collectively have an adverse effect on health
status, function or quality of life and that require complex
healthcare management, decision-making, or coordin-
ation [2]. For this study we chose to adopt the strategy
recently presented by Barnett et al. [10] from Scotland,
and looked at the prevalence of the same forty chronic
conditions amongst our patients (Table 1). This comparisonis relevant as Scotland is a nation of comparable size
to Israel which also has a national health care insurance
system. MHS, the second largest health management
organization in Israel, provides care for two million enrol-
lees (one quarter of the Israeli population), and thus is es-
pecially suited for such a study.
Methods
Study design and participants
This cross-sectional study was conducted in MHS, which
insures approximately two million members. In Israel,
universal healthcare services are provided by four health
maintenance organizations that are obligated to insure
every citizen who wishes to join them irrespective of age,
sex, or medical history. Therefore every sector in the Is-
raeli population is represented in MHS. MHS has used
electronic medical records for over twenty years, and a
unified patient chart now allows all providers to view
Table 2 Characteristics of Maccabi Healthcare Services
study population (year 2012) and people registered with
314 medical practices in Scotland (2007) [1]
MHS (n = 1972798) Scotland (n = 1751841)
n % n %
Sex F 1009745 51.2% 884420 50.5%
M 963053 48.8% 867421 49.5%
Age <=24 842069 42.7% 479156 27.4%
25-44 574386 29.1% 508389 29.0%
45-64 405067 20.5% 473127 27.0%
65-84 135679 6.9% 254600 14.5%
85+ 13468 0.7% 36569 2.1%
MCC 0 686406 34.8% 1012980 57.8%
1 534222 27.1% 333365 19.0%
2 311986 15.8% 167518 9.6%
3 173749 8.8% 99487 5.7%
4 101292 5.1% 60417 3.4%
5 62161 3.2% 35641 2.0%
6 39962 2.0% 20507 1.2%
7 25284 1.3% 11080 0.6%
8 or above 37736 1.9% 10846 0.6%
MCC, multimorbidity.
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tral databases are automatically updated with every mem-
ber transaction including all physician visits, prescriptions
dispensed, laboratory tests, medical treatments, nursing
care, physiotherapy treatment, hospital admissions, out-
patient visits or any other medical service rendered to the
insured individual through MHS, who is issued a unique
identification number.
Data collection
The data for this analysis were collected from all active
MHS members alive on August 6, 2012. The dataset in-
cluded age, sex, and socioeconomic status. Socioeconomic
status (SES) was categorized into ten levels according to the
poverty index of the member’s enumeration area as defined
by the 1995 national census based on several parameters,
including household income, educational qualifications,
crowding, material conditions and car ownership [18].
To assess MCC, we followed the method presented by
Barnett et al. [10] and selected 40 disorders (Table 1),
which were defined by clinical coding and prescription
data. In addition to the diagnosis of learning disability
we also coded for Attention Deficit Disorder (ADHD).
For several morbid conditions we used data from MHS’
automated patients’ registries including the cancer regis-
try, the diabetes mellitus patient registry [19,20], the car-
diovascular disease registry [21], the hypertension registry
[22] and the mental health registry [23]. These registries
are updated daily and automatically utilizing strict algo-
rithms. The algorithms draw data from numerous sources
including physicians’ diagnoses, prescription information,
data acquired from hospital discharge codes and billing
information from providers. We defined multimorbidity
(multiple chronic conditions; MCC) as the presence of
two or more of these morbidities in one patient. Similar to
Barnett et al. [10] we defined each disorder as either a
physical or mental health disorder.
Statistical analyses
We calculated age-specific prevalence and frequency of
MCC and compared them to the results published by
Barnett et al. [10] for the Scottish population. Analyses
were stratified by socio-economic status ranging from 1
(highest) to 10 (lowest). Difference in age and sex distri-
bution between MHS and the Scottish population were
calculated by Chi-square test. Confidence intervals (CI)
were calculated with Fisher’s exact method. Statistical
analyses were conducted using IBM-SPSS statistics (ver-
sion 20). The study protocol has been approved by the
MHS Research Ethics Committee.
Results
The total study population included in the present analysis
was 1,972,798 individuals. Children and adults youngerthan 25 years accounted for 43% of this population com-
pared to 27% in the Scottish study (Table 2) [10]. The
Scottish study population has a higher proportion of eld-
erly individuals (17%) compared to 8% in MHS (P < 0.01).
A total of 65.2% (95% CI 65.1%-65.3%) of the population
had one or more chronic morbidities, and 38.1% (38.0%–
38.2%) had two or more chronic disorders, i.e. MCC.
These are significantly (P < 0.01) higher rates compared
with 42.2% (42.1%-42.3%) and 23.2% (23.1%-23.3%) in the
Scottish study population, respectively. In the age-specific
analysis, the prevalence of MCC increased with age from
0.4% in infants and young children aged under five years
to 28.1% in the 40-44 year age group, to over 90% after
age 75 (Figure 1). While similar results were calculated for
children, the respective prevalence rates among the adult
Scottish study population were 15% for 40-44 year olds
and 81% after age 85.
The number of disorders per patient increased substan-
tially with increasing age (Figure 2). In the 45-49 year age
group, two thirds (63.7%) of the population had at least
one chronic disorder, and one third (35.5%) had two or
more morbidities (MCC). Between ages 70-74, 95.2% of
the group had at least one chronic disorder and 85.5% had
MCC. One quarter of the younger adolescents (10-14
years old) and one third of the older adolescents (15-19
years old), had at least one chronic condition. The most
prevalent disorder in these age groups was learning dis-












<5 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+
Scotland MHS
Figure 1 Age-specific prevalence of multimorbidity in MHS and Scotland [10].
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year olds), respectively. Asthma and other pulmonary dis-
eases were reported in 0.7% and 6.1% of these age groups,
respectively.
Residing in high SES level was associated with a low
prevalence of MCC, particularly between age 35 and
65 years (Figure 3). In the 45- 49 age group, MCC was
recorded in 42.1% of the individuals in the lowest SES
compared with 30.6% in the highest level. The respective
prevalence rates in the Scottish population were 26.8%
and 13.4% for this age group. No substantial differences
were observed in the older age groups, while among
young adolescents (10-14 years old) a positive association
was calculated between SES level and MCC prevalence
(3.8% in the lowest SES level compared to 4.3% in the
highest level).
Discussion
In our large cohort, representing approximately one quar-
ter of the Israeli population, MCC is very prevalent, in-
creases with age and with the exception of children and
adolescents is more prevalent in lower than higher socio-
economic strata. Not only is MCC associated with age,
the severity of MCC, as determined by the number ofchronic disorders accrued per person, increases with
age. Of special interest are the young age at which MCC
becomes evident, and its distribution in our cohort. The
main diagnoses contributing to MCC in children in our
cohort were asthma, learning disabilities and visual distur-
bances. The high prevalence of asthma in young children
in our population, is in accordance with data from the
USA where a diagnosis of asthma was given to 8.3%,
14.4% and 18.7% of children in age groups <5, 5-11 and
12-17 year old, respectively [24]. Additionally in our popu-
lation asthma was more prevalent in lower SES groups
[24]. In addition to a high prevalence of asthma (6.8%),
children aged 5-10 in our population were diagnosed as
having learning disabilities (5.8%) and visual impairment
(2.1%) leading to MCC at a very young age.
Of particular interest in our cohort is the distribution
of MCC across socioeconomic status and patient age. In
contrast with previously reported studies, higher preva-
lence of MCC was recorded in higher socioeconomic sta-
tus groups, particularly amongst adolescents and young
adults. This difference was mostly driven by the diagnosis
of learning disabilities. One explanation could be that hav-
ing a recorded diagnosis of learning disability entitles stu-
dent patients to adjustments and extra time in high school
Figure 2 Number of chronic disorders by age-group.
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provided after didactic, psychological and/or medical diag-
nosis, a process that is more easily accessed by those with
means through the private sector, leading to a bias of the
wealthy in this regard. The higher prevalence of learning
disorders in younger than older children might be ex-
plained by an increase emphasis put on diagnosing this
disorder in Israeli society in recent years. After the age of
30 the difference in MCC amongst the SES groups per age
is in the order of 10% or less (a much tighter range than
that observed in the Scottish population) attesting to a so-
cially equitable health system in Israel.
Compared to the data from Scotland [10] we found a
higher prevalence of MCC across all age groups. Is our
population truly more ill than the Scottish population,
have the MHS cohort been over-diagnosed, or have diag-
noses been made in a more conservative mode in the
Scottish cohort? One possibility could be that MHS has
been using electronic databases for over two decades,
thus diagnoses of chronic disease are not lost. The an-
swer though is not possible to say from the data at hand,
an additional study designed to answer the difference
would be needed, yet the comparison of the two popula-
tions does lead to some interesting observations.At ages 50-54 the rate of MCC was double that which
was found in the Scottish cohort (46.7% vs 28%). Al-
though in this paper we took the same approach in
evaluating the data as Barnett et al. [10], differences in
the way diagnoses are recorded in the two systems may
account for some of the differences between the results
of the two studies. In our system every medical condi-
tion is recorded in a unified electronic medical record
that tracks chronic medical conditions throughout the
lifespan of citizens. This recording method that has been
used during the last twenty years lends itself to accumu-
lation of chronic conditions from young age.
In comparison with the Scottish population described by
Barnett et al. [10] our study population is much younger.
The Israeli population in general is younger than the aver-
age age of the Organization for Economic Co-operation
and Development (OECD) nations. At the end of 2011
28.2% of the Israeli population was younger than 15 years
old in comparison with the average of the OECD nations
of 18.5%. Additionally in Israel only 10.3% and less were
older than 65 years compared with a 15% average for the
OECD nations [26]. Although the data are age specific, dif-
ferences in the rate of diagnoses of chronic diseases may
be attributed to differences in care practice for children in
Figure 3 Prevalence of multimorbidity by age and socioeconomic status.
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healthcare care systems provide universal health insurance
with a very generous health basket and low copayments
for primary and secondary care, there are some differences.
According to the 2013 OECD report, the percentage of pe-
diatricians amongst Israeli physicians is almost double that
in the United Kingdom (9.38% in Israel versus 5.43% in the
UK) and the density of pediatricians per 1,000 population
is also double (0.3 in Israel versus 0.15 in the UK) [27].
The high prevalence of learning disabilities in Israel, per-
haps, is enabled by high accessibility to pediatric care com-
bined with a tendency of wealthier parents to establish the
condition given the advantages in school that it entitles to
children.
The prevalence of MCC presents challenges to mod-
ern health systems and providers. In this regard, the use
of integrated electronic medical records made it possible
for provider and health care system managers to com-
prehend the magnitude and complexity of MCC. The
challenges to providers are significant, for example in
trying to use the fewest necessary drugs possible, with
the least side effects, to devise a personalized effective
and safe treatment plan for each patient. Healthcare sys-
tem managers are interested in optimizing the use of
scarce resources efficiently in order to obtain maximalhealth of the population. In this regard the study of local
patterns of MCC is of utmost importance.
In order for healthcare systems to effectively approach
the treatment of chronic disorders, the multidimen-
sional Chronic Care Model (CCM) was developed by
Wagner et al. [28]. Though this model was subsequently
thought to be both efficacious and cost-reducing [29], the
phenomenon of MCC, not covered in the original CCM
or by most other treatment guidelines, has emerged as
one of the most important challenges to modern health-
care systems.
Management must provide caretakers with new, more
complex educational tools and supportive information
technology to help achieve best possible results. This
should include seminars and lectures not only on
discrete diseases but also on the efficient management of
disease combinations such as diabetes mellitus, hyper-
tension, hyperlipidemia and chronic renal failure. A recent
Cochrane review which looked at studies examining inter-
ventions for improving outcomes in patients with MCC in
primary care and community settings, concluded that
though the research in the field is scarce, there are indica-
tions that interventions targeted at either specific combi-
nations of diseases, or at specific problems for patients
with multiple conditions may be most effective [30].
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morbid patients demanding and not easily delegated to
nurses [5], attesting to the high work burden currently
faced by caregivers, a burden which can be expected to
increase in coming years. It can be expected that along
with an increased workload, physicians will experience
increased burnout, and it is of utmost importance that
health management systems set up support systems for
their caretakers in order to minimize this phenomenon.
New systems of healthcare need to be devised to handle
the needs of patients with MCC. New decision support
tools for caregivers based on information technologies
are needed at point of care. Undoubtedly future health-
care systems dealing with MCC will include team work
that will encompass a wide variety of medical and para-
medical caregivers including, but not limited to, physi-
cians and nurses along with dieticians, social workers,
physiotherapists, clinical pharmacologists and consultant
physicians all working in unison to adjust goals and
comprehensive treatment plans to meet the goals and
demands of the individual patient with MCC. Moreover
it is expected that new technologies utilizing telemedi-
cine and advanced technologies will be implemented in
the care of these patients. Tools that help patients cope
with the complex medical instructions and that enable
better active participation in the monitoring and man-
aging of MCC are needed.
A limitation to our study is the use of census data from
1995 in analysis of the association of MCC with socioeco-
nomic status. It will be important to update our analysis
as new and reliable census data becomes available.
Conclusions
The current data indicates that MCC is highly prevalent
in all age groups in Israel. A high prevalence of MCC
has far-reaching implications in the planning of health
care systems. As patients live longer lives and accrue
chronic disorders, both mental and physical, the man-
agement of combinations of these disorders becomes
more and more complex. There is therefore an increas-
ing need for tertiary as well as secondary and primary
prevention to prevent poor outcomes of combinations of
chronic disorders. Finally, but most important, as suc-
cinctly pointed out to by Guthrie et al. [31] clinical guide-
lines which provide the basis of modern day clinical care
must be improved and adapted to account for patients
with MCC.
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